Wallace Daniel F
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006 Australia.
Clin Biochem Rev. 2016 May;37(2):51-62.
Iron is an essential element in biology, required for numerous cellular processes. Either too much or too little iron can be detrimental, and organisms have developed mechanisms for balancing iron within safe limits. In mammals there are no controlled mechanisms for the excretion of excess iron, hence body iron homeostasis is regulated at the sites of absorption, utilisation and recycling. This review will discuss the discoveries that have been made in the past 20 years into advancing our understanding of iron homeostasis and its regulation. The study of iron-associated disorders, such as the iron overload condition hereditary haemochromatosis and various forms of anaemia have been instrumental in increasing our knowledge in this area, as have cellular and animal model studies. The liver has emerged as the major site of systemic iron regulation, being the location where the iron regulatory hormone hepcidin is produced. Hepcidin is a negative regulator of iron absorption and recycling, achieving this by binding to the only known cellular iron exporter ferroportin and causing its internalisation and degradation, thereby reducing iron efflux from target cells and reducing serum iron levels. Much of the research in the iron metabolism field has focussed on the regulation of hepcidin and its interaction with ferroportin. The advances in this area have greatly increased our knowledge of iron metabolism and its regulation and have led to the development of novel diagnostics and therapeutics for iron-associated disorders.
铁是生物学中的一种必需元素,众多细胞过程都需要它。铁过多或过少都可能有害,生物体已形成在安全范围内平衡铁的机制。在哺乳动物中,没有控制多余铁排泄的机制,因此机体铁稳态在吸收、利用和再循环部位进行调节。本综述将讨论过去20年中在增进我们对铁稳态及其调节的理解方面所取得的发现。对与铁相关疾病的研究,如铁过载疾病遗传性血色素沉着症和各种形式的贫血,以及细胞和动物模型研究,都有助于增加我们在这一领域的知识。肝脏已成为全身铁调节的主要部位,是产生铁调节激素铁调素的地方。铁调素是铁吸收和再循环的负调节因子,它通过与唯一已知的细胞铁输出蛋白铁转运蛋白结合,使其内化和降解,从而减少铁从靶细胞的外流并降低血清铁水平。铁代谢领域的许多研究都集中在铁调素的调节及其与铁转运蛋白的相互作用上。这一领域的进展极大地增加了我们对铁代谢及其调节的认识,并导致了针对与铁相关疾病的新型诊断方法和治疗方法的开发。